Nabumetone
RELAFEN DS
Nonsteroidal Anti-inflammatory Drug
NADAC/unit
$0.1283
No Shortage
Tier 1: 71.1%
8 Manufacturers
17 ANDAs
Nabumetone reduces pain, inflammation, and fever by inhibiting prostaglandin synthesis.
vs. brand RELAFEN DS: Generic saves up to 99% per unit
Generic Manufacturers
ANNORA PHARMA PRIVATE LTDCHARTWELL MOLECULES LLCCHARTWELL RX SCIENCES LLCINVAGEN PHARMACEUTICALS INCLGM PHARMA SOLUTIONS LLCNOVITIUM PHARMA LLCSCIEGEN PHARMACEUTICALS INCWATSON LABORATORIES INC
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.
